52 related articles for article (PubMed ID: 21417935)
1. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.
Khanna R; Madhavan SS; Bhanegaonkar A; Remick SC
J Womens Health (Larchmt); 2011 May; 20(5):739-47. PubMed ID: 21417935
[TBL] [Abstract][Full Text] [Related]
2. Declining mammography screening in a state Medicaid Fee-for-Service program: 1999-2008.
Bhanegaonkar A; Madhavan SS; Khanna R; Remick SC
J Womens Health (Larchmt); 2012 Aug; 21(8):821-9. PubMed ID: 22568434
[TBL] [Abstract][Full Text] [Related]
3. Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States.
Patel AM; Chang E; Paydar C; Reddy SR
J Med Econ; 2023; 26(1):811-820. PubMed ID: 37285853
[TBL] [Abstract][Full Text] [Related]
4. Increased Emergency Department Utilization and Costs for Medicare Cancer Patients with Malnutrition Diagnoses.
Sulo S; Brunton C; Drawert S; Watson G; Hegazi R; Bastasch M
J Nutr Health Aging; 2022; 26(8):786-791. PubMed ID: 35934823
[TBL] [Abstract][Full Text] [Related]
5. The cost of breast cancer screening in the Medicare population.
Gross CP; Long JB; Ross JS; Abu-Khalaf MM; Wang R; Killelea BK; Gold HT; Chagpar AB; Ma X
JAMA Intern Med; 2013 Feb; 173(3):220-6. PubMed ID: 23303200
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication.
Frois C; O'Connell T; Pesa J; Fastenau J
J Health Econ Outcomes Res; 2013; 1(1):54-61. PubMed ID: 34430660
[No Abstract] [Full Text] [Related]
7. Expenditures for Persons Living With HIV Enrolled in Medicaid, 2006-2010.
Fleishman JA; Monroe AK; Voss CC; Moore RD; Gebo KA
J Acquir Immune Defic Syndr; 2016 Aug; 72(4):408-15. PubMed ID: 26977747
[TBL] [Abstract][Full Text] [Related]
8. Estimation of Breast Cancer Incident Cases and Medical Care Costs Attributable to Alcohol Consumption Among Insured Women Aged <45 Years in the U.S.
Ekwueme DU; Allaire BT; Parish WJ; Thomas CC; Poehler D; Guy GP; Aldridge AP; Lahoti SR; Fairley TL; Trogdon JG
Am J Prev Med; 2017 Sep; 53(3S1):S47-S54. PubMed ID: 28818245
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries.
Chapel JM; Ritchey MD; Zhang D; Wang G
Am J Prev Med; 2017 Dec; 53(6S2):S143-S154. PubMed ID: 29153115
[TBL] [Abstract][Full Text] [Related]
10. Cost of breast cancer based on real-world data: a cancer registry study in Italy.
Capri S; Russo A
BMC Health Serv Res; 2017 Jan; 17(1):84. PubMed ID: 28122558
[TBL] [Abstract][Full Text] [Related]
11. Health Burden and Service Utilization in Texas Medicaid Deliveries from the Prenatal Period to 1 Year Postpartum.
Salahuddin M; Matthews KJ; Elerian N; Ramsey PS; Lakey DL; Patel DA
Matern Child Health J; 2022 May; 26(5):1168-1179. PubMed ID: 35386030
[TBL] [Abstract][Full Text] [Related]
12. Utilization of West Virginia Pediatric Medicaid Claims Data to Guide Outpatient Antimicrobial Stewardship Interventions.
Kilgore JT; Lanata MM; Willis JM; McCarthy MJ; Becker JB; Evans JE; Smith MJ
J Pediatric Infect Dis Soc; 2022 Apr; 11(4):172-176. PubMed ID: 34939655
[TBL] [Abstract][Full Text] [Related]
13. What affects the public healthcare costs of breast cancer in New Zealand?
Lao C; Mondal M; Kuper-Hommel M; Campbell I; Lawrenson R
Asia Pac J Clin Oncol; 2023 Aug; 19(4):482-492. PubMed ID: 36114604
[TBL] [Abstract][Full Text] [Related]
14. First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan.
Watanabe T; Goto R; Yamamoto Y; Ichinose Y; Higashi T
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574371
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Breast Cancer Survivors Among Canadian Women.
Kirkham AA; Jerzak KJ
J Natl Compr Canc Netw; 2022 Sep; 20(9):1005-1011. PubMed ID: 36075384
[TBL] [Abstract][Full Text] [Related]
16. Estimating the Cancer Treatment Cost for 5 Common Types of Cancer with Separating Out-of-Pocket and Governmental Costs in Afghanistan, 2020.
Rohani H; Mousavi SH; Hashemy SM; Jafari S; Amiry GY; Bhandari D; Ozaki A; Hashemy T
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3273-3279. PubMed ID: 36308349
[TBL] [Abstract][Full Text] [Related]
17. Hospitalization and ambulatory costs related to breast cancer due to physical inactivity in the Brazilian state capitals.
Silva DAS
PLoS One; 2022; 17(1):e0261019. PubMed ID: 35045087
[TBL] [Abstract][Full Text] [Related]
18. 'At All Costs': Breast Cancer Patient Responses to Cost Transparency and Communication.
Gutnik LA; Fish LJ; Gallagher J; Greenup RA
Ann Surg Oncol; 2022 Nov; 29(12):7259-7260. PubMed ID: 35810230
[No Abstract] [Full Text] [Related]
19. Medical cost of breast cancer services in Serbia between 2010 and 2019: national data report.
Rancic N; Todorovic M; Stepovic M; Vekic S; Kostic D; Ratkovic M; Radevic S; Simic R; Dragojevic Simic V
Front Public Health; 2024; 12():1378886. PubMed ID: 38605875
[No Abstract] [Full Text] [Related]
20. ASCO 2021 Insights on Breast Cancer Research: An Interview with Dr. Virginia Kaklamani.
Oncologist; 2021 Jul; 26 Suppl 3(Suppl 3):S1-S2. PubMed ID: 34184793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
